AtriCure, Inc. (ATRC) Posts Q3 EPS Loss of $0.07
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
- Walmart shares fall despite earnings beat
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
